scispace - formally typeset
G

Gerald R. Cunha

Researcher at University of California, San Francisco

Publications -  373
Citations -  30733

Gerald R. Cunha is an academic researcher from University of California, San Francisco. The author has contributed to research in topics: Mesenchyme & Epithelium. The author has an hindex of 95, co-authored 365 publications receiving 29563 citations. Previous affiliations of Gerald R. Cunha include Monash University, Clayton campus & Baylor College of Medicine.

Papers
More filters
Journal ArticleDOI

Carcinoma-associated fibroblasts direct tumor progression of initiated human prostatic epithelium.

TL;DR: In this paper, the authors demonstrate that fibroblasts associated with carcinomas stimulate tumor progression of initiated nontumorigenic epithelial cells both in an in vivo tissue recombination system and in vitro coculture system.
Journal ArticleDOI

Prostate cancer in a transgenic mouse.

TL;DR: The establishment of breeding lines of transgenic mice that reproducibly develop prostate cancer provides an animal model system to study the molecular basis of transformation of normal prostatic cells and the factors influencing the progression to metastatic prostate cancer.
Journal ArticleDOI

The Endocrinology and Developmental Biology of the Prostate

TL;DR: The most extensively studied gland of this group is the prostate, which is found exclusively in mammals and produces many components of semen such as fructose, zinc ions, and various proteins important for the formation of the copulatory plug in rodents.
Journal ArticleDOI

Roles for Nkx3.1 in prostate development and cancer

TL;DR: It is shown that the murine Nkx3.1 homeobox gene is the earliest known marker of prostate epithelium during embryogenesis and is subsequently expressed at all stages of prostate differentiation in vivo as well as in tissue recombinants.
Journal ArticleDOI

Estrogen Receptor β Inhibits Human Breast Cancer Cell Proliferation and Tumor Formation by Causing a G2 Cell Cycle Arrest

TL;DR: It is demonstrated that ERβ-selective estrogens may lack breast cancer promoting properties exhibited by estrogens in hormone replacement regimens and may be useful for chemoprevention of breast cancer.